Keyphrases
Treatment Response
100%
Drug Treatment
100%
Drug Survival
100%
Survival Response
100%
Drug Safety
100%
Refractory Sarcoidosis
100%
Abatacept
100%
Safety Response
100%
Tofacitinib
100%
Sarcoidosis
50%
Tumour Necrosis Factor Inhibitor (TNFi)
25%
Therapeutic Potential
12%
Treatment Discontinuation
12%
Treatment Group
12%
Disease Duration
12%
Prednisolone
12%
Serious Adverse Events
12%
Median Range
12%
Routine Care
12%
Disease-modifying Antirheumatic Drugs (DMARDs)
12%
High Response Rate
12%
Non-responders
12%
Reasons for Discontinuation
12%
Biologic DMARDs
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sarcoidosis
100%
Abatacept
100%
Tofacitinib
100%
Adverse Event
12%
Receptor
12%
Disease Duration
12%
Prednisolone
12%